ParkerVision Q1 net loss $0.7M; patent trials set for Dec 2024, Jan 2025

PARKERVISION INC

2024-Q1 EPS reported -$0.01

Net loss $0.7M ($0.01/share) vs net income $13.1M ($0.16/share) in Q1 2023, which included a $25M patent settlement.
Cash used in operations $0.8M; ended quarter with $1.7M cash.
Jury trials scheduled: MediaTek Dec 2024, Realtek Jan 2025 in Western District of Texas.
Favorable claim construction rulings received in Jan 2024 against MediaTek and Realtek.
Awaiting CAFC decision in ParkerVision v. Qualcomm after Nov 2023 oral arguments.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

PARKERVISION INC reported the three months ended March 31, 2024 results: net income net loss for the first quarter of 2024 of $0.7 million, or $0.01 per common share, EPS $0.01 per common share.

Period: the three months ended March 31, 2024
Net income: net loss for the first quarter of 2024 of $0.7 million, or $0.01 per common share
EPS: $0.01 per common share
Result: reported results

Exact text from the filing

ParkerVision reported a net loss for the first quarter of 2024 of $0.7 million, or $0.01 per common share, compared to net income of $13.1 million, or $0.16 per common share for the first quarter of 2023.

View on SEC.gov

1047 earnings releases filed in the last 30 days. Browse all earnings releases →

PARKERVISION INC filing history →

Source: SEC EDGAR

accession 0001437749-24-016612

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.